(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID, 95.0%, 1g

{[3-(2-pyrazinyl)-1H-1,2,4-triazol-5-yl]methyl}amine dihydrochloride hydrate, 95.0%, 1g

1-(4-Cyanophenyl)-2-thiourea, 98%, 1g

4,6-Dimethylbenzofuran-2-carboxylic acid, 95%, 1g

Allyl 4-((methylamino)methyl)piperidine-1-carboxylate, 97%, 5g

(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Ibrutinib Impurity), 97%, 50mg

(R)-(-)-1,2-Propanediol>97.0%(GC)5g

2-(Benzyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 500mg

5-Amino-2-(trifluoromethyl)pyridine, 97.0%, 1g

MULBERROSIDE A, 95%, 10mg

Hexamethylene Diisocyanate>98.0%(GC)100mL

Wide-neck container ROTILABO® PETG, 2000 ml, 4 Piece(s)

4-Methyl-6-trifluoromethyl-pyridin-2-ol, 95.0%, 5g